Connect Biopharma Holdings Stock Forecast for 2023 - 2025 - 2030

Updated on 04/30/2024

Stock Rating
2
Price Target
$7.00
Consensus
Outperform
Upside
508.70%
Analysts
0
Stock Rating
2
Upside
508.70%
Analysts
0
Price Target
$7.00

Connect Biopharma Holdings Stock Forecast and Price Target

The average target price set lately by experts for Connect Biopharma Holdings to reach by the end of the year is $7.00, which would imply a potential upside of approximately 508.7 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $7.00 and a low estimate of $7.00.

$7.00

508.70% Upside

Buy
Buy

Connect Biopharma Holdings Fair Value Forecast for 2023 - 2025 - 2030

Connect Biopharma Holdings Revenue Forecast for 2023 - 2025 - 2030

Connect Biopharma Holdings Dividend per Share Forecast for 2023 - 2025 - 2030

Connect Biopharma Holdings Free Cash Flow Forecast for 2023 - 2025 - 2030

Connect Biopharma Holdings EBITDA Forecast for 2023 - 2025 - 2030

Connect Biopharma Holdings EBIT Forecast for 2023 - 2025 - 2030

Connect Biopharma Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030